On October 23, Unilever PLC rose 3.59% in Regular Trading, trading at $66.7/share, with turnover of $115 million.

The move followed confirmation that the company agreed to sell first-aid and bandage brand Welly Health to Forward Consumer Partners, with the transaction expected to close by the end of the year and financial terms not disclosed.

The divestiture fits Unilever PLC's broader portfolio-reshaping strategy. Earlier, the company reported second-quarter underlying sales growth of 5.8%, turnover of 13.05 billion euros, and raised its full-year underlying sales growth outlook to 4% to 6%, reinforcing investor focus on core categories and operating efficiency.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)